Aratana Therapeutics Files Registration Statement for Proposed Initial Public Offering

Aratana Therapeutics, a biopharmaceutical company focused on licensing, developing and commercializing innovative prescription medications for cats and dogs , announced today that it has filed a registration statement on Form S-1 with the SEC relating to the proposed initial public offering of its common stock.